PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.10%
Negative revenue growth while ON stands at 32.61%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-6.45%
Negative gross profit growth while ON is at 16.87%. Joel Greenblatt would examine cost competitiveness or demand decline.
8.36%
EBIT growth below 50% of ON's 19.27%. Michael Burry would suspect deeper competitive or cost structure issues.
-5.45%
Negative operating income growth while ON is at 19.27%. Joel Greenblatt would press for urgent turnaround measures.
8.16%
Net income growth under 50% of ON's 998.02%. Michael Burry would suspect the firm is falling well behind a key competitor.
4.00%
EPS growth under 50% of ON's 1250.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
4.08%
Diluted EPS growth under 50% of ON's 1200.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.51%
Share reduction while ON is at 0.36%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.10%
Diluted share reduction more than 1.5x ON's 1.69%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
31.30%
Dividend growth of 31.30% while ON is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-1.84%
Negative OCF growth while ON is at 72.87%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
0.24%
FCF growth under 50% of ON's 82.23%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
45.31%
10Y revenue/share CAGR under 50% of ON's 140.63%. Michael Burry would suspect a lasting competitive disadvantage.
13.86%
5Y revenue/share CAGR under 50% of ON's 77.20%. Michael Burry would suspect a significant competitive gap or product weakness.
22.94%
3Y revenue/share CAGR under 50% of ON's 86.23%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
141.93%
10Y OCF/share CAGR above 1.5x ON's 36.70%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
62.92%
5Y OCF/share CAGR 1.25-1.5x ON's 50.30%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
26.13%
3Y OCF/share CAGR under 50% of ON's 91.54%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
131.02%
Positive 10Y CAGR while ON is negative. John Neff might see a substantial advantage in bottom-line trajectory.
300.73%
5Y net income/share CAGR at 75-90% of ON's 381.58%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
123.41%
3Y net income/share CAGR 50-75% of ON's 180.66%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
35.88%
Below 50% of ON's 719.88%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
9.07%
Below 50% of ON's 34.00%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
5.67%
Below 50% of ON's 31.77%. Michael Burry suspects a serious short-term disadvantage in building book value.
1168.08%
Stable or rising dividend while ON is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
194.90%
Dividend/share CAGR of 194.90% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
66.90%
3Y dividend/share CAGR of 66.90% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-12.44%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.00%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.33%
Asset growth at 50-75% of ON's 1.97%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
2.34%
Under 50% of ON's 4.81%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.06%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-2.83%
Our R&D shrinks while ON invests at 25.38%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-7.01%
We cut SG&A while ON invests at 21.96%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.